"Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA." The New England Journal of Medicine, 2023
hazard ratio 2.08, 95% CI 1.83 to 2.36)
The extended duration allows for consistent, sustainable loss without extreme measures that compromise muscle retention or metabolic health
Confidence Restoration: Break the cycle of performance anxiety by allowing your brains natural arousal mechanisms to take the lead
-endorphin, the POMC-derived opioid peptide, has the capacity to upregulate melanogenesis and melanin distribution by promoting maturation of melanocytes and arborisation of their dendritic processes, thus increasing the efficacy of the transfer and distribution of melanosomes to neighbouring keratinocytes [23, 29]